Article Details

Chinese startup Epigenic Therapeutics raises funding worth $20 M - BioSpectrum Asia

Retrieved on: 2022-08-09 17:56:32

Tags for this article:

Click the tags to see associated articles and topics

Chinese startup Epigenic Therapeutics raises funding worth $20 M - BioSpectrum Asia. View article details on hiswai:

Excerpt

Series Pre-A funding is jointly invested by Morningside Venture Capital, Kingray Capital, Trinity Innovation Fund and TigerYeah Capital.

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up